Nigerian Equities See Profit-Taking as Dangote IPO Looms
Nigerian stocks fell 1.6% last week, with insurers leading the decline. Investors are shifting focus to the upcoming $1.6 billion Dangote Refinery listing.
Nigerian equities experienced a 1.6% decline last week as profit-taking swept through most sectors, leaving oil and gas as the sole exception. The insurance index suffered the heaviest drop, falling 5.5%, and remains the only sector with a negative year-to-date return. According to reporting by GN stocks/banks, this correction occurred ahead of a significant shift in market attention toward the primary market.
Investment bank United Capital Plc advised that investors should prioritize companies demonstrating strong earnings, attractive valuations, and stable dividend payments. This guidance comes as the market prepares for the launch of Dangote Refinery's $1.6 billion initial public offering, which is expected to draw significant liquidity away from the secondary market this week.
Transcorp and GTCO show strong fundamentals
Transcorp was highlighted for trading below its intrinsic value, supported by a net profit ratio of 24.7 and a price-to-earnings ratio of 4.5x. Its 10-day relative strength index stood at 31.5, indicating potential technical oversold conditions. Similarly, Guaranty Trust Holding Company was selected for its fundamental strength, posting an NPR of 37.4 and a P/E of 5.4x with a neutral RSI of 47.8.
These metrics suggest that both firms offer value relative to their earnings power. The low P/E ratios imply that the market is currently pricing in lower growth expectations or higher risk, creating a valuation gap that fundamental investors may view as an opportunity despite the broader sector weakness.
Insurance and microfinance metrics vary
In the insurance sector, AXA Mansard showed an NPR of 3.4 and a P/E of 29.8x, with an RSI of 47.3. While the high P/E suggests premium valuation relative to earnings, the company remains in focus due to its market position. In contrast, NPF Microfinance Bank presented a P/E of 7.2x and a deeply oversold RSI of 22.5, reflecting the sharp drop in the insurance and financial indices last week.
Pharmaceuticals offer mixed valuation signals
Pharmaceutical firm Neimeth rounded out the selection with an NPR of 12.2 and a P/E of 33.2x. Its RSI of 40.8 indicates mild bearish momentum but not extreme oversold conditions. The inclusion of Neimeth alongside financial and insurance stocks illustrates a strategy of diversifying across sectors while adhering to strict fundamental criteria for earnings quality and valuation discipline.
